Protalix BioTherapeutics, Inc. (PLX)
Market Open
26 Oct, 06:41 PM
$
2. 50
-0.05
-2.1569%
$
205.46M Market Cap
12.78 P/E Ratio
- Div Yield
290,980 Volume
0.21 Eps
$ 2.55
Previous Close 
Want to track PLX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
| | | 0.04 | - |
| | | - | - |
| | | 0.11 | - |
| | | - | - |
| | | 0.07 | 0.09 |
| | | 0.06 | 0.03 |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | 6.8 | 7.7 |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
PLX Earnings Reports FAQ
What is the earnings per share (EPS) for PLX?
The current EPS is 0.21.
What is the company's earnings growth rate?
Over the past 13 years, the earnings growth rate has been approximately -39%, reflecting the PLX's performance and AMEX market conditions.
When is the next earnings release date?
Protalix BioTherapeutics, Inc has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Protalix BioTherapeutics, Inc are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for PLX at this time, as Protalix BioTherapeutics, Inc has no recent EPS data to calculate it.
2026 © Marketlog. All Rights Reserved.
